Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines
The use of nanoparticles encapsulating messenger RNA (mRNA) as a vaccine has recently attracted much attention because of encouraging results achieved in many nonviral genetic antitumor vaccination studies. Notably, in all of these studies, mRNA nanoparticles are passively targeted to dendritic cell...
Saved in:
Main Author: | Kyle K. L. Phua |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/680620 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonviral targeted mRNA delivery: principles, progresses, and challenges
by: Xi He, et al.
Published: (2025-01-01) -
Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
by: Yeqi Li, et al.
Published: (2025-02-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01) -
Editorial: Building public confidence in innovative mRNA vaccines
by: Jia Hu, et al.
Published: (2025-01-01) -
Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)